In Vitro Human Immunodeficiency Virus Type 1 Resistance Selections With Combinations of Tenofovir and Emtricitabine or Abacavir and Lamivudine
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00816-06
Full Text
Open PDFAbstract
Available in full text
Date
September 18, 2006
Authors
Publisher
American Society for Microbiology